NCT00361426

EarlySense Monitoring Device Evaluation on COPD, CHF and Pneumonia Patients

EarlySense Monitoring Device Evaluation on Patients in Med / Surg

• Status: Withdrawn
• Phase: —
• Study type: Observational
• Enrollment: 0 (actual)
• Sponsor: EarlySense Ltd. · Industry
• Sex: All
• Age: 18 Months
• Healthy volunteers: Not accepted

Summary

Continuous measurement of breathing patterns, heart rate, restlessness and cough in sleep using EarlySense ES 16 device. Predicting worsening in COPD patients' condition using the above parameters.

Detailed description

Study's participants are CHF, COPD and Pneumonia patients or patients who are otherwise hospitalized in internal medicine department. During the study the patients' breathing patterns, heart rate, restlessness and cough in sleep will be measured by the EarlySense ES 16 device, which is placed in the patients' bed. Patients' clinical status are followed. The patient's clinical condition is followed and analyzed in comparison to the EarlySense system output in order to determine the capability of the EarlySense system to predict COPD, CHF or Pneumonia deteriorations.

Conditions

• COPD Patients

Interventions

Type	Name	Description
DEVICE	Earlysense vital sign monitor	The system is a contactless system that measures heart and respiratory rates and other parameters via a contactless sensor that is placed under the patient mattress

Timeline

• Start date: 2008-01-01
• Primary completion: 2009-02-01
• Completion: 2009-02-01
• First posted: 2006-08-08
• Last updated: 2016-07-19

Locations

1 site across 1 country: Israel